Experimental

A new vaccine that appears to stop Alzheimer's in its tracks is adding to optimism that this could be the beginning of the end for the disease.  A study of the jab in mice found that not only did the shot clear harmful amyloid plaque from…

Investigators at the Icahn School of Medicine at Mount Sinai have designed an innovative RNA-based strategy to activate dendritic cells -- which play a key role in immune response -- that eradicated tumors and prevented their recurrence in…

Eli Lilly's experimental drug donanemab slowed the progression of Alzheimer's by 60% for patients in the earliest stages of the brain-wasting disease, according to trial data presented at a medical meeting on Monday.…

A groundbreaking dental medicine in Japan is progressing towards clinical trials, aiming to become the world's first tooth-regrowing treatment, as reported by the Mainichi, a national news site.The trial will focus on patients affected by…

An experimental vaccine that could wipe out the threat of gonorrhea has been fast-tracked by the Food and Drug Administration.The sexually transmitted infection (STI) is the second most common in the US and is alarming officials because it…

The search for five missing passengers on board an experimental submersible is now over, winding down one of the largest joint search and rescue responses in American and Canadian history.As police and officials now comb through the facts…

Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.Cristina Arias | Cover | Getty ImagesEli Lilly’s experimental drug helped patients lose up to 24% of their weight after almost a year, the highest…

Doctors and scientists in Lausanne, Switzerland helped a paralyzed man stand, walk, and even climb stairs, after implanting devices in his brain and on his spinal cord that are connected using artificial intelligence.   The procedure is a…

Novo Nordisk said that it was cutting the supply of some doses of its popular obesity drug in the U.S. as it struggles to keep up with surging demand.Liselotte Sabroe | Afp | Getty ImagesNovo Nordisk's high-dose experimental obesity pill…

Pavlo Gonchar | Lightrocket | Getty ImagesPfizer on Monday said it would stop developing its experimental obesity and diabetes pill, lotiglipron, due to elevated liver enzymes in patients who took the drug once a day in mid-stage clinical…